Minimize Uncertainty – Make Informed Decisions – Succeed

Public_Health

Public Health Weekly News - October 3rd 2025

October 3, 2025cardiovascular risk factors,biologics and biosimilars,precision medicine,Public Health News,BioPharma and Tech News,asthma treatment,Cancer prevention,Environmental Health,respiratory medicine,neuropsychiatric disorders,autism research,ALS therapy,immune checkpoint inhibitors,dementia risk,sleep and brain healthCOVID-19 variants,ovarian cancer research

Public Health Update: Asthma Therapy, Autism Genetics, ALS Pathways, Cancer in…

by LucidQuest

Respiratory

Respiratory Video Recap—October 3, 2025

October 3, 2025rxc007,respiratory clinical trials,BioPharma and Tech News,Respiratory News,vapendavir,Tezepelumab,AIRSUPRA,Tyvaso,treprostinil,Tezspire,clesrovimab,albuterol budesonide,omalizumab biosimilar,xolair,deupirfenidonelyr-100,zelasudil

Watch Our Video Summary Capturing Top Respiratory News from the Last Two……

by LucidQuest

Vaccines

Latest Vaccine Research News - Sept 19th - Oct 2nd 2025

October 3, 2025KRAS vaccine,COVID-19 booster,EMA,BioPharma and Tech News,melanoma vaccine,breast cancer vaccine,pneumococcal vaccine,Elicio Therapeutics,Anixa Biosciences,IO Biotech,fungal vaccine,Evaxion A/S,Appili Therapeutics,Vitalex Biosciences,HIPRANMRC

Watch Our Video Summary Capturing Top Vaccine News from the Last Two Weeks…

by LucidQuest

2025_Pharma CVC Investments Trends

BioPharma Corporate Venture Capital (CVC) Investment Trends

October 3, 2025Women’s health innovation,Biopharma market trends,Our Insights,Venture Capital Trends,google ventures,abbvie ventures,small-molecule therapeutics,BioPharma Corporate Venture Capital,CVC investment trends,Pharma venture capital,AI in biopharma,Digital health investments,Gene and cell therapy,Antibody-based therapeutics,Oncology investmentsImmunology innovation,CNS and neurodegeneration

The rapid evolution of BioPharma Corporate Venture Capital Investment Dive…

by LucidQuest

Respiratory

Respiratory Today—October 3, 2025

October 3, 2025pulmonary arterial hypertension,respiratory therapeutics,merck,Respiratory News,COPD,BioPharma and Tech News,Idiopathic Pulmonary Fibrosis,Altesa BioSciences,ATyr Pharma,Pulmonary Sarcoidosis,Enanta,Endeavor BioMedicines,PureTech Health,Redx Pharma,AmnealDiagonal Therapeutics,Zymeworks

Respiratory Health Update: Vapendavir COPD Win, WINREVAIR PAH Impact,…

by LucidQuest

Vaccines

Vaccines Weekly News - October 3rd 2025

October 3, 2025Candida albicans,NIAID,BioPharma and Tech News,Vaccine news,Dengue Vaccine,pneumococcal vaccine,AI Immunology,Virometix,synthetic vaccine,Takeda Biopharmaceuticals,Novo Medi Sciences,PCV13 booster,Evaxion,personalized cancer vaccine,Naval Medical Research CommandStaphylococcus aureus vaccine,fungal vaccine

Vaccine Research Update: Pneumococcal Advances, Dengue Review, Cancer Data,…

by LucidQuest

Cell_Gene_Therapy

Latest Cell and Gene Therapy News - Sept 17th to Oct 1st

October 2, 2025LCA5,nusinersen,Spinraza,FDA CBER,Duchenne Muscular Dystrophy,Cell and Gene Therapy News,Huntington's disease,Hemophilia A,BioPharma and Tech News,Biogen,IgG4 Related Disease,deramiocel,Uplizna,inebilizumab,AMT-130,Valoctocogene RoxaparvovecCapricor,Opus Genetics

Watch Our Video Summary Capturing Top Cell and Gene News from the Last Two…

by LucidQuest

Rare Disease news

Rare Diseases Weekly News - October 2nd 2025

October 2, 2025Cure Rare Disease,lonafarnib,JR-446,CRD-003,MoCD Type A,Dyne,BioPharma and Tech News,LGMD2i,HGPS,DYNE-251,MPS IIIB,R9,PDPL,DMD exon 51,Acromegaly,FKRP,Arialys,DELIVER,Odevixibat,AAV MYO2,ART5803,Evkeeza,Regeneron,GeneDx,ANRE,evinacumab,J-Brain Cargo,Infinity,RPDD,ANGPTL3,Ipsen,ExomeDx,Korea reimbursement,HoFH,Paltusotine,GenomeDx,SNUH,Rare Disease News,PALSONIFY,AAP,BRF2,Crinetics,Er-Kim,SeCys-tRNA,SST2 agonist,Sentynl,GPX4,Sanofi Ventures,Nulibry,selenium,Bylvay,fosdenopterin,JCR,PFICZokinvy,Medipal

🧬 This Week in Rare Diseases: Sanofi’s $625M Venture Boost, FDA Orphan Nod,…

by LucidQuest

Cardiovascular

Cardiovascular Weekly News - October 2nd 2025

October 2, 2025sex differences in MI,WHO South-East Asia,Plaque Analysis,SEAHEARTS,crispr,IVUS,protocol-based HTN diabetes care,AI,Cigna coverage,Relief Cardiovascular,semaglutide,510(k),transcatheter implant,HeartFlow,Global Burden of Disease,heart failure congestion,BioPharma and Tech News,DALYs,CityUHK,Novo Nordisk,modifiable risk factors,genome editing,Mayo Clinic,BGI Genomics,eLNPs,BioCardia,multi-omics,IND enabling,CardiAMP cell therapy,polygenic risk,SOUL,refractory angina,EJPC,PAD,chronic myocardial ischemia,European Commission,MALE,JACC,EU Cardiovascular Health Plan,MACE,SCAD,JACARDI,Cardiovascular Newsembolism,Ambient Air Quality Directive

Cardiovascular Update: CardiAMP cell therapy, GBD special report, EU steps up…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - October 2nd 2025

October 2, 2025in vivo CAR-T,Capricor,pediatric logMAR,CGT GMP hub,PUL v2.0,Umoja,patents,ASEAN,CRL,UB-VV111,astrazeneca,YouthBio,Verismo,Fast Track,BioPharma and Tech News,YB002,SynKIR-110,CD19,LVEF,partial reprogramming,STAR-101,TranC,DMD,FDA CGT draft guidances,mesothelin,TnpB,Alzheimers,CBER,Miltenyi Bioindustry,Cas12,Biogen,RWD,LVV,RNA splitting,deramiocel,innovative designs,Factor Bioscience,AAV exit,HOPE-3,Integrated DNA Technologies,mRNA TALENs,restructuring,eXmoor Pharma,Aldevron,Cellectis,Cell and Gene Therapy News,Siam Bioscience,Alt-R HDR Enhancer Protein,autoimmune,Aera Therapeutics,HDR,Opus Genetics,AERA-109,iPSC,LCA5,tLNPHSPC,AAV8

Gene & Cell Therapy Update: eXmoor × Siam Bioscience Partnership, FDA Fast…

by LucidQuest

Neuroscience

Latest Neuroscience News - Sept 16th to Sept 30th

October 1, 2025Alexion,AstraZeneca Rare Disease,abbvie,J-Brain Cargo,novartis,JUST-AAV,roche,AMT-130,sanofi,uniQure,Genentech,Kesimpta,BioPharma and Tech News,ofatumumab,Eli Lilly,ublituximab-xiiy,BTK Inhibitor,Kisunla,tolebrutinib,donanemab,TG Therapeutics,Tavapadon,BRIUMVI,D1/D5 partial agonist,Ocrelizumab,Neuroscience NewsRituximab,JCR Pharmaceuticals

Watch Our Video Summary Capturing Top Neuroscience News from the Last Two……

by LucidQuest

Immunology

Immunology Weekly News - October 1st 2025

October 1, 2025TRE-515,tLNP,deoxycytidine kinase,in vivo CAR-T,abbvie,dCK,shared decision-making,BioPharma and Tech News,Allergan Aesthetics,endoscopic remission,IBD,AA Signature,University of Oslo,Odevixibat,AMWC Dubai,CTNNB1S37F,Johnson & Johnson,MD Codes,TCR therapy,Deucravacitinib,TYK2 inhibitor,Nature Immunology,Sotyktu,Eliquis,Immunology News,Ipsen,apixaban,Bristol Myers Squibb,Bylvay,EndoQuest Robotics,PFIC,Endoluminal Surgical System,Korea NHI,ELS System,Aera Therapeutics,PARADIGM trial,AERA-109Trethera,targeted LNP

Immunology Update: EndoQuest Robotics, $1.8M NIH grant, BMS Patient Connect and…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.